These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4648433)

  • 1. Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugs.
    Turek I; Kurland AA; Hanlon TE; Bohm M
    Br J Psychiatry; 1972 Dec; 121(565):605-12. PubMed ID: 4648433
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome].
    Elie R; Morin L; Tétreault L
    Encephale; 1972; 61(1):32-52. PubMed ID: 4403697
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology of tardive dyskinesia. Part II.
    Jus A; Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Villeneuve R
    Dis Nerv Syst; 1976 May; 37(5):257-61. PubMed ID: 1261344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Late dyskinesia caused by neuroleptics. Survey on 1,660 psychiatric hospital patients].
    Bourgeois M; Graux C; Arrethche-Berthelot N
    Ann Med Psychol (Paris); 1976 May; 1(5):737-46. PubMed ID: 970829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa; Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract]   [Full Text] [Related]  

  • 6. Tardive dyskinesia: an evaluation of the etiologic association with neuroleptic therapy.
    Baldessarini RJ
    Can Psychiatr Assoc J; 1974 Dec; 19(6):551-4. PubMed ID: 4613452
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudoparkinsonism and tardive dyskinesia.
    Crane GE
    Arch Neurol; 1972 Nov; 27(5):426-30. PubMed ID: 5078897
    [No Abstract]   [Full Text] [Related]  

  • 8. The membrane actions of tranquilizers in relation to neuroleptic-induced parkinsonism and tardive dyskinesia.
    Seeman P; Staiman A; Lee T; Chau-Wong M
    Adv Biochem Psychopharmacol; 1974; 9(0):137-48. PubMed ID: 4151919
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with fluspirilene in psychoses.
    Svestka J; Náhunek K; Hádlík J; Rodová A
    Act Nerv Super (Praha); 1971; 13(3):173-4. PubMed ID: 5113825
    [No Abstract]   [Full Text] [Related]  

  • 11. Polygraphic studies of tardive dyskinesia and of the rabbit symdrome during different stages of sleep.
    Villeneuve A; Jus K; Jus A
    Biol Psychiatry; 1973 Jun; 6(3):259-74. PubMed ID: 4732255
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A; Vereecken JL
    Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
    [No Abstract]   [Full Text] [Related]  

  • 13. [Late complications in neuroleptic therapy].
    Viukari M
    Duodecim; 1976; 92(4):159-62. PubMed ID: 1253746
    [No Abstract]   [Full Text] [Related]  

  • 14. Tardive dyskinesia in schizophrenic patients treated with psychotropic drugs.
    Crane GE
    Agressologie; 1968; 9(2):209-18. PubMed ID: 5675488
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurologic syndromes associated with antipsychotic-drug use.
    N Engl J Med; 1973 Jul; 289(1):20-3. PubMed ID: 4708951
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-action neuroleptic agents (delayed-action neuroleptics)].
    Ginestet D; Péron-Magnan P
    Rev Prat; 1972 Apr; 22(12):1941-53. PubMed ID: 4675045
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the question of possible irreversible disorders due to psychopharmacotherapy].
    Meyer HH
    Arch Psychiatr Nervenkr (1970); 1966; 208(4):345-59. PubMed ID: 5969585
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cholinergic and anticholinergic agents on tardive dyskinesia.
    Klawans HL; Rubovits R
    J Neurol Neurosurg Psychiatry; 1974 Aug; 37(8):941-7. PubMed ID: 4418481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia and drug therapy in geriatric patients.
    Crane GE; Smeets RA
    Arch Gen Psychiatry; 1974 Mar; 30(3):341-3. PubMed ID: 4813137
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of drug withdrawal on tardive dyskinesia.
    Crane GE; Ruiz P; Kernohan WJ; Wilson W; Royalty N
    Act Nerv Super (Praha); 1969; 11(1):30-5. PubMed ID: 5770140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.